VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
semaglutide우선순위 중간ICSR 검토기타

LITERATURE DETAIL · PMID 42562129

Integrating GLP-1 Receptor Agonists Into Dermatology Practice: Safety and Monitoring Strategies.

Integrating GLP-1 Receptor Agonists Into Dermatology Practice: Safety and Monitoring Strategies.

저자
Shanthi Narla, Radhika R Narla
저널
Clinics in dermatology
공개일
2026 Aug 06
연구 유형
기타
DOI
10.1016/j.clindermatol.2026.07.030

문헌 요약

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have rapidly expanded beyond the treatment of type 2 diabetes mellitus (T2DM) and obesity, with increasing relevance to dermatologic practice as more patients present while receiving these therapies. This medication class now includes oral formulations including oral semaglutide and the first non-peptid…

PV 검토 포인트

개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.

PubMed에서 원문 정보 보기